Please login to the form below

influenza

This page shows the latest influenza news and features for those working in and with pharma, biotech and healthcare.

UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’

Human challenge studies have been used previously to support the development of treatments for a range of disease, including malaria, typhoid, cholera, norovirus and influenza.

Latest news

Sanofi reports a profit in Q4 as Dupixent sales climb

Vaccines sales were also up 14.6%, thanks to demand for Sanofi's influenza vaccines and higher Polio/Pertussis/Hib (PPH) vaccines.
Roche’s flu pill Xofluza gains EU approval

Xofluza offers patients the first novel mechanism of action for treating influenza approved in Europe in almost 20 years. ... found that the drug had a statistically significant prophylactic effect on influenza occurrences.
Roche’s Xofluza pill wins FDA approval for post-exposure flu prevention

Xofluza was first approved by the FDA last year, and is available as a treatment for acute, uncomplicated influenza in people aged 12 years and older. ... We’re hopeful that reducing the burden of influenza may help to mitigate the strain on our
Sanofi’s quadrivalent flu vaccine Supemtek scores EU approval

Sanofi’s Supemtek is the now first and only recombinant influenza vaccine to be approved within the European Union. ... countries. “In the context of the COVID-19 pandemic, preventing influenza remains a public health priority,” said Thomas Triomphe
AZ’s COVID-19 vaccine proves promising in elderly participants, new data shows

A number of studies have shown that a decreasing immune function caused by ageing results in a decreased immune response to vaccines, with this response previously observed for vaccines for influenza

More from news
Approximately 19 fully matching, plus 207 partially matching documents found.

Latest Intelligence

How will COVID-19 affect uptake of vaccinations against other diseases?

worldwide, Dr Schaffner had a point to call attention to the dangers of influenza. ... As such, policymakers are continuing to stress the importance of planning for seasonal influenza circulation this winter.
‘It’s not about you, it’s about them’ – putting customer needs first in our communications

By Chris Finch. Pre-COVID-19, the H1N1 influenza pandemic of 1918 was the most severe global pandemic in modern history.
Effectively communicating in a public health crisis

In John M Barry’s 2009 Nature essay titled Pandemics: Avoiding the Mistakes of 1918, he said: ‘In the next influenza pandemic.
Biotech profile: Tom Evans, CEO, Vaccitech.

What are the shortcomings of current influenza vaccines, and why are new products needed? ... The outcome measurement is to decrease the amount of laboratory-confirmed influenza illness.
Case study: Break the flu cycle

76% of delegates felt more confident in their ability to manage the influenza vaccination. ... influenza infection, particularly among the more at-risk group of 65 years and over.

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

Ex-Roche CMO Sandra Horning joins Gilead’s board of directors

During her ten-year career at Roche, Horning helped to bring 15 new medicines to patients in a range of diseases, including cancer, multiple sclerosis, influenza and blindness.
Germany's Ventaleon names biotech entrepeneur CEO

patients suffering from serious infections such as influenza to get better, faster.
Dr Michael Watson appointed as president of Valera

Dr Watson brings twenty years of vaccines expertise to the role and has broad experience in the development and licensing of vaccines for conditions such as smallpox, encephalitis and influenza.
NDA Group appoints Bill Griffiths as general manager, UK

systems teams as well as a specialist influenza vaccines unit.
Takeda appoints head of vaccines development

Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programmes for dengue, norovirus and seasonal influenza.

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

Case study

influenza vaccine.
Fake News is Bad for your Health

Epidemics of measles are occurring across Europe. Rates of vaccination for influenza, HPV, tetanus and polio have also declined.
To track disease, follow the money

The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.
Influenza

Agency: BASTARD. LONDON. Product: Self Promotion. Client: Self Promotion. Therapy area: Self Promotion. View the PMHub profile for: BASTARD. LONDON.

More from PMHub
Approximately 2 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Digital project manager: Competitive

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Digital account director: Competitive

Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...: Highly competitive salary

Account Manager - Healthcare Consultancy: Salary depending on experience

Digital strategist: Competitive

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

FREELANCE (Outside IR35) Opportunities for this week below!!!: Superb Day Rate

Client Services Director +, Remote or London – Leadership Opport...: Highly Competitive Salary, Bonus &Benefits

PMHub

Add my company

Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel: Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor: Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story: Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....

Email:
Password:

Please login to the form below

influenza

COVID-19 Updates and Daily News

Featured jobs

Quick links